Keyword search

Filter results by

Search Help
Currently selected filters that can be removed

Keyword(s)

Survey or statistical program

40 facets displayed. 0 facets selected.

Content

1 facets displayed. 0 facets selected.
Sort Help
entries

Results

All (661)

All (661) (0 to 10 of 661 results)

  • Articles and reports: 82-003-X202600500001
    Description: Previous research has found variability in cancer incidence and cancer-related outcomes according to place of residence. This study examined geographic variability in the incidence and mortality of breast cancer among females in Canada, using data from the 2021 Canadian Cancer Registry (breast cancer incidence) and the Canadian Vital Statistics – Death database (breast cancer mortality). Age-standardized incidence rates (ASIRs) and age-standardized mortality rates (ASMRs) per 100,000 females per year and their rate ratios were calculated, as well as age group-specific and age-standardized stage-specific incidence rates, and examined across provinces and territories, community sizes, and peer groups (i.e., clusters of health regions with similar socioeconomic and demographic characteristics).
    Release date: 2026-05-20

  • Articles and reports: 82-003-X202600500002
    Description: Breast cancer is the most commonly diagnosed cancer among women in Canada. Breast density substantially influences breast cancer risk and mammography performance. However, OncoSim-Breast, a Canadian microsimulation model representing breast cancer control, including cancer onset, screening, and survival, has not previously explicitly accounted for breast density. This study describes the incorporation of density-specific parameters—prevalence, relative risk of breast cancer, and digital mammography performance (sensitivity and specificity)—using data from five Canadian provinces, into the OncoSim-Breast model. Calibration experiments and internal validations were conducted to ensure the updated OncoSim-Breast model aligned with observed data from the Canadian Cancer Registry.
    Release date: 2026-05-20

  • Stats in brief: 11-627-M2026019
    Description: This infographic explores trends in Canadians’ weight over time, as well as how obesity may impact health.
    Release date: 2026-04-09

  • Articles and reports: 82-003-X202600300001
    Description: Body mass index (BMI) is commonly used to estimate obesity prevalence; however, reliance on BMI alone can lead to an incomplete understanding of obesity’s impact on health. In line with the 2025 recommendations of the Lancet Diabetes & Endocrinology Commission, this study used measured and self-reported data from the 2016 to 2019 Canadian Health Measures Survey to combine population-level measures of excess adiposity with indicators of physiological dysfunction and activity limitation across eight body system domains. Clinical and preclinical obesity were characterized by excess adiposity and progressive obesity-related impairment among Canadian adults.
    Release date: 2026-03-18

  • Table: 13-10-0326-01
    Geography: Canada
    Frequency: Occasional
    Description: Cardiovascular health measures of the household population, by sex and age group.
    Release date: 2026-03-10

  • Table: 13-10-0111-01
    Geography: Canada, Province or territory
    Frequency: Annual
    Description:

    Number and rate of new cancer cases diagnosed annually from 1992 to the most recent diagnosis year available. Included are all invasive cancers and in situ bladder cancer with cases defined using the Surveillance, Epidemiology and End Results (SEER) Groups for Primary Site based on the World Health Organization International Classification of Diseases for Oncology, Third Edition (ICD-O-3). Random rounding of case counts to the nearest multiple of 5 is used to prevent inappropriate disclosure of health-related information.

    Release date: 2026-02-27

  • Table: 13-10-0747-01
    Geography: Canada, Province or territory
    Frequency: Annual
    Description:

    The number of new cases, age-standardized rates and average age at diagnosis of cancers diagnosed annually from 1992 to the most recent diagnosis year available. Included are all invasive cancers and in situ bladder cancer with cases defined using the Surveillance, Epidemiology and End Results (SEER) Groups for Primary Site based on the World Health Organization International Classification of Diseases for Oncology, Third Edition (ICD-O-3). Cancer incidence rates are age-standardized using the direct method and the final 2011 Canadian postcensal population structure. Random rounding of case counts to the nearest multiple of 5 is used to prevent inappropriate disclosure of health-related information.

    Release date: 2026-02-27

  • Table: 13-10-0141-01
    Geography: Canada
    Frequency: Annual
    Description: Number of deaths caused by certain infectious and parasitic diseases, by age group and sex, 2000 to most recent year.
    Release date: 2026-01-13

  • Table: 13-10-0142-01
    Geography: Canada
    Frequency: Annual
    Description: Number of deaths caused by neoplasms, by age group and sex, 2000 to most recent year.
    Release date: 2026-01-13

  • Table: 13-10-0144-01
    Geography: Canada
    Frequency: Annual
    Description: Number of deaths caused by endocrine, nutritional and metabolic diseases, by age group and sex, 2000 to most recent year.
    Release date: 2026-01-13
Data (226)

Data (226) (40 to 50 of 226 results)

  • Table: 13-10-0867-01
    Geography: Canada
    Frequency: Occasional
    Description: Long term symptoms were defined as having COVID-19 symptoms at least 3 months after a self-reported positive test or suspected SARS-CoV-2 infection. Results on the status of long-term symptoms only included respondents for whom a period of three months separated their self-reported date of infection and the date they completed the questionnaire.
    Release date: 2023-08-03

  • Table: 13-10-0868-01
    Geography: Canada, Geographical region of Canada, Province or territory
    Frequency: Occasional
    Description: This survey provides new evidence about those who indicated on their electronic questionnaire a positive test result with either a positive polymerase chain reaction (PCR) test or a rapid antigen test (RAT), as well as those who suspected that they had an infection. These results are based on the individual's self-reported first positive test result or first suspected infection and does not account for multiple infections.
    Release date: 2023-08-03

  • Table: 35-10-0194-01
    Geography: Canada, Province or territory
    Frequency: Annual
    Description: Incident-based fire statistics, by type of casualty, age group of casualty, status of casualty, cause of death or injury and reason for non-evacuation, Canada, Nova Scotia, New Brunswick, Ontario, Manitoba, Saskatchewan, Alberta, British Columbia, Yukon, Canadian Armed Forces, 2005 to 2021.
    Release date: 2023-06-08

  • Table: 35-10-0195-01
    Geography: Canada, Province or territory
    Frequency: Annual
    Description: Incident-based fire statistics, by type of casualty, age group of casualty, status of casualty and type of structure, Canada, Nova Scotia, New Brunswick, Ontario, Manitoba, Saskatchewan, Alberta, British Columbia, Yukon, Canadian Armed Forces, 2005 to 2021.
    Release date: 2023-06-08

  • Table: 35-10-0196-01
    Geography: Canada, Province or territory
    Frequency: Annual
    Description: Incident-based fire statistics, by performance of smoke alarm device, residential fires and type of incident and casualty, Canada, Nova Scotia, New Brunswick, Ontario, Manitoba, Saskatchewan, Alberta, British Columbia, Yukon, Canadian Armed Forces, 2005 to 2021.
    Release date: 2023-06-08

  • Table: 35-10-0197-01
    Geography: Canada, Province or territory
    Frequency: Annual
    Description: Incident-based fire statistics, by performance of sprinkler system, structural fires and type of incident and casualty, Canada, Nova Scotia, New Brunswick, Ontario, Manitoba, Saskatchewan, Alberta, British Columbia, Yukon, Canadian Armed Forces, 2005 to 2021.
    Release date: 2023-06-08

  • Public use microdata: 13-25-0009
    Description: This public use microdata file (PUMF) provides researchers access to data on the distribution of SARS-CoV-2 lineages detected in the Canadian provinces between May and September 2022. Samples were collected as part of the Canadian COVID-19 Antibody and Health Survey (CCAHS), Cycle 2. The PUMF file consists of a subset of participants of the CCAHS who submitted a positive PCR saliva sample over the course of the collection of the survey. The PUMF contains select demographic information including sex at birth, age group, province and the week of collection. The file also contains SARS-CoV-2 whole genome sequences and its associated data.
    Release date: 2023-05-25

  • Table: 13-10-0840-01
    Frequency: Occasional
    Description:

    Annual percent change and average annual percent change in age-standardized cancer incidence rates since 1984 to the most recent diagnosis year. The table includes a selection of commonly diagnosed invasive cancers, as well as in situ bladder cancer. Cases are defined using the Surveillance, Epidemiology and End Results (SEER) Groups for Primary Site based on the World Health Organization International Classification of Diseases for Oncology, Third Edition (ICD-O-3) from 1992 to the most recent data year and on the International Classification of Diseases, ninth revision (ICD-9) from 1984 to 1991.

    Release date: 2023-05-16

  • Table: 13-10-0865-01
    Geography: Canada, Geographical region of Canada, Province or territory
    Frequency: Semi-annual
    Description: This table presents a series of indicators relating to the COVID-19 pandemic, including relating to perceptions of Canadians' mental health, precautions they've taken, willingness to receive vaccine and the number of vaccinated and unvaccinated persons. Estimates are based on preliminary bi-annual data from the Canadian Community Health Survey, and are provided for the Canadian population aged 18 and older excluding the territories, by region of residence and other demographic characteristics.
    Release date: 2023-04-25

  • Table: 13-10-0866-01
    Geography: Canada, Geographical region of Canada, Province or territory
    Frequency: Occasional
    Description: Dried blood spot testing was used to detect antibodies against SARS-CoV-2, the virus that causes COVID-19. The proportion of Canadians who have antibodies from infection is referred to as the seroprevalence of SARS-CoV-2.
    Release date: 2023-03-27
Analysis (414)

Analysis (414) (30 to 40 of 414 results)

  • Articles and reports: 82-003-X202300500001
    Description: Research has identified an association between sleep and obesity in the general population, it is also important to examine this association in the military population. This study presents the prevalence of overweight, obesity, sleep duration and measures of sleep quality in the Canadian Armed Forces. In addition, the independent associations of sleep duration and sleep quality with obesity are examined.
    Release date: 2023-05-17

  • Articles and reports: 82-003-X202300400001
    Description: To date, population estimates of hypertension prevalence among children and adolescents in Canada have been based on clinical guidelines in the National High Blood Pressure Education Program’s 2004 Fourth Report on the Diagnosis, Evaluation, and Treatment of High Blood Pressure in Children and Adolescents (NHBPEP 2004). In 2017, the American Academy of Pediatrics published updated guidelines in Clinical Practice Guideline for Screening and Management of High Blood Pressure in Children and Adolescents (AAP 2017), followed by Hypertension Canada in 2020 with its publication of Comprehensive Guidelines for the Prevention, Diagnosis, Risk Assessment, and Treatment of Hypertension in Adults and Children (HC 2020). This is the first study in Canada to compare the national estimates of the prevalence of child and adolescent hypertension based on AAP 2017 with estimates of prevalence based on NHBPEP 2004 and HC 2020. The main objectives of this analysis were to apply AAP 2017 and HC 2020 to all six cycles of Canadian Health Measures Survey data available to date and examine the effect on population estimates of hypertension prevalence by sex and age group among children and adolescents aged 6 to 17. This study also examines the impact of applying AAP 2017 across time and selected characteristics, describes those who are reclassified into a higher BP category under AAP 2017, and examines differences in hypertension prevalence resulting from applying HC 2020 versus AAP 2017.
    Release date: 2023-04-19

  • Articles and reports: 82-003-X202300300002
    Description: Previous studies examining the cardiometabolic risks associated with physical activity (PA) in workers have predominantly used self-reported measures. Little is known about workers’ distinct daily PA patterns and whether these are linked with cardiometabolic risks. This study examined associations between patterns of workers’ accelerometer-measured daily PA and four markers of cardiometabolic health. Furthermore, the study examined similarities and differences between younger compared to middle-aged and older workers, and between men and women, to understand whether these groups are associated with different cardiometabolic risks.
    Release date: 2023-03-15

  • Articles and reports: 82-003-X202300100001
    Description: Cancer survival estimates provide insights into the effectiveness of early detection and treatment. The stage of cancer at diagnosis is an important determinant of survival, reflecting the extent and spread at the time of disease detection. The recent extension of the Canadian Cancer Registry death-linked analytic file from 2014 to 2017 now offers an opportunity to provide more up-to-date net survival (NS) figures and to profile, for the first time, five-year NS estimates for Canada (excluding Quebec). This study presents five-year stage-specific cancer and five-year NS estimates for the most commonly diagnosed cancers in Canada.
    Release date: 2023-01-18

  • Articles and reports: 82-003-X202201200001
    Description:

    The prevalence of diabetes mellitus in adults is increasing in Canada and worldwide, due to population aging as well as various social, environmental, and genetic factors. The objective of this study was to examine different individual and neighbourhood characteristics and their independent associations with risk of hospitalization for diabetes (type 1 or type 2) and selected commonly comorbid conditions among the high-risk Canadian adult population.

    Release date: 2022-12-21

  • Stats in brief: 11-629-X2022003
    Description:

    COVID-19 has changed the way we think about health data and analysis at Statistics Canada. This presentation will track the impact of the pandemic on health and highlight how Statistics Canada has been responsive to evolving health data needs by: identifying research priorities; developing new content and making projections into the future; and producing dissemination products for multiple target audiences.

    Release date: 2022-12-21

  • Articles and reports: 82-003-X202201100002
    Description:

    Considering the difficulties experienced by individuals with chronic conditions in accessing health care prior to the pandemic, and their potential risk for adverse COVID-19 outcomes, it is necessary to understand how their access to health care was affected by the pandemic, relative to others. This study used data from the Survey on Access to Health Care and Pharmaceuticals During the Pandemic to estimate the proportion of individuals in Canada, with and without chronic conditions, who experienced difficulties accessing health care services during the pandemic.

    Release date: 2022-11-16

  • Articles and reports: 82-003-X202200600002
    Description:

    An evaluation of progress in cancer survival in Canada for all cancer types combined was recently conducted using the cancer survival index. This study provides a comprehensive evaluation of provincial-level progress in cancer survival for all cancer types combined in Canada.

    Release date: 2022-06-15

  • Articles and reports: 82-003-X202200600003
    Description:

    Canadian immigrants from countries where the hepatitis B virus (HBV) and hepatitis C virus (HCV) are endemic may be at higher risk of liver-related disease than Canadian-born residents. This study compared HBV- and HCV-related hospitalizations in Canadian immigrants (arriving from 1980 to 2013) and long-term residents (Canadian-born population and pre-1980 immigrants) and aimed to describe the burden of disease in both groups.

    Release date: 2022-06-15

  • Articles and reports: 82-003-X202200400001
    Description: Canadians have been gravely impacted by the COVID-19 pandemic, and adults living with children may have been disproportionately impacted. The objective of this study was to describe changes in chronic disease risk factors and current exercise habits among adults living with and without a child younger than 18 years old.
    Release date: 2022-04-20
Reference (21)

Reference (21) (0 to 10 of 21 results)

  • Surveys and statistical programs – Documentation: 82-225-X200701010508
    Description:

    The Record Linkage Overview describes the process used in annual internal record linkage of the Canadian Cancer Registry. The steps include: preparation; pre-processing; record linkage; post-processing; analysis and resolution; resolution entry; and, resolution processing.

    Release date: 2008-01-18

  • Surveys and statistical programs – Documentation: 82-225-X
    Description:

    The compendium of Canadian Cancer Registry procedures manuals set out the rules for reporting cancer data to the CCR for all provincial and territorial cancer registries.

    Release date: 2008-01-18

  • Surveys and statistical programs – Documentation: 82-225-X20070109648
    Description:

    The Record Linkage Overview describes the process used in annual internal record linkage of the Canadian Cancer Registry. The steps include: preparation; pre-processing; record linkage; post-processing; analysis and resolution; resolution entry; and, resolution processing.

    Release date: 2007-06-21

  • Surveys and statistical programs – Documentation: 82-225-X20070109650
    Description:

    The User Guide to Record Linkage Feedback Reports C1 and C2 is intended for the users of the reports. The reports were developed to facilitate the exchange of information and decisions between the Canadian Cancer Registry and the Provincial and Territorial Cancer Registries.

    Release date: 2007-06-21

  • Surveys and statistical programs – Documentation: 82-225-X20060099202
    Description:

    The User Guide to Record Linkage Feedback Reports C1 and C2 is intended for the users of the reports. The reports were developed to facilitate the exchange of information and decisions between the Canadian Cancer Registry and the Provincial and Territorial Cancer Registries.

    Release date: 2006-07-07

  • Surveys and statistical programs – Documentation: 82-225-X20060099203
    Description:

    The user guide to Death Clearance Feedback Reports is intended for users of the feedback reports. The feedback reports were developed to facilitate the exchange of information and decisions between the Canadian Cancer Registry and the Provincial and Territorial Cancer Registries.

    Release date: 2006-07-07

  • Surveys and statistical programs – Documentation: 82-225-X20060099204
    Description:

    The Record Linkage Overview describes the process used in annual internal record linkage of the Canadian Cancer Registry. The steps include: preparation; pre-processing; record linkage; post-processing; analysis and resolution; resolution entry; and, resolution processing.

    Release date: 2006-07-07

  • Surveys and statistical programs – Documentation: 82-225-X20060099205
    Description:

    The Death Clearance Overview document describes the Death Clearance module of the Canadian Cancer Registry, its structure, its function and its role in the operation of the national cancer registry. Inputs and outputs are listed and briefly described, as well as the different steps constituting the Death Clearance process.

    Release date: 2006-07-07

  • Surveys and statistical programs – Documentation: 82-225-X20060099206
    Description:

    The Guidelines for Abstracting and Determining Death Certificate Only Cases are intended for use by all provincial and territorial cancer registries during their Death Clearance Process. The guidelines should be used when performing a comparison between the Death Certificate Notification and the cancer registry database.

    Release date: 2006-07-07

  • Surveys and statistical programs – Documentation: 82-619-M2006003
    Description:

    This document examines the functional limitations, physical, emotional and social, related to the musculoskeletal conditions having the largest impact on the health of Canadians. These functional limitations are described and classified using the Classification and Measurement System of Functional Health (CLAMES).

    These descriptions and classifications are the first step in a new approach to measuring the health of Canadians that examines what factors are adversely affecting population health and how to address them. This document also provides health professionals, advocacy groups, and individual Canadians with an overview of how living with certain musculoskeletal conditions affects day-to-day functioning.

    Release date: 2006-04-04